Practical guidance for treatment of patients with diabetes using flash glucose monitoring: A pilot study | Skip to main content

07-08-2018 | Flash glucose monitoring | Article

Practical guidance for treatment of patients with diabetes using flash glucose monitoring: a pilot study

Journal: Diabetology & Metabolic Syndrome

Authors: Keiko Koide, Koichiro Azuma, Jun Nojima, Kenichiro Kodama, Yoshihito Atsumi

Publisher: BioMed Central




Flash glucose monitoring (FGM) is a factory-calibrated, blood glucose measuring sensor system for patients with diabetes. We aimed to investigate the correlation between the sensor glucose (SG) value obtained using an FGM device and the traditional self-monitoring of blood glucose (SMBG) value.


In 30 patients with diabetes under insulin treatment, SG and SMBG values were measured for 2 weeks, and the correlation between the values was analyzed.


The mean number of accumulated measurements of SG values was 1223.2 ± 193.0, whereas that of the SMBG values was 49.2 ± 21.3. Although SG and SMBG values showed a favorable correlation (R2 = 0.8413), SG values were lower than SMBG values by an average of 7.9 ± 29.8 mg/dL. The correlation patterns fell into four types: low type (SG values lower than SMBG values; n = 12), high type (SG values higher than SMBG values; n = 3), cross type (the slope of the two regression lines crossed at a certain measurement value; n = 14), and matching type (the values overlapped; n = 1).


Recognition of the characteristic correlation patterns between SG and SMBG values is indispensable for certified diabetes educators to provide appropriate treatment guidance to patients with diabetes.
Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389–94. CrossRefPubMedPubMedCentral
American Diabetes Association. 6. Glycemic targets. Diabetes Care. 2017;40:S48–56. CrossRef
Carlson AL, Mullen DM, Bergenstal RM. Clinical use of continuous glucose monitoring in adults with type 2 diabetes. Diabetes Technol Ther. 2017;19:S4–11. CrossRefPubMed
Grunberger G, Bailey T, Camacho PM, et al. Proceedings from the american association of clinical endocrinologists and american college of endocrinology consensus conference on glucose monitoring. Endocr Pract. 2015;21:522–33. CrossRefPubMed
Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:d3805. CrossRefPubMedPubMedCentral
Basu A, Dube S, Slama M, et al. Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes. 2013;62:4083–7. CrossRefPubMedPubMedCentral
Hoss U, Budiman ES, Liu H, Christiansen MP. Feasibility of factory calibration for subcutaneous glucose sensors in subjects with diabetes. J Diabetes Sci Technol. 2014;8:89–94. CrossRefPubMedPubMedCentral
Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015;17:787–94. CrossRefPubMedPubMedCentral
Kamath A, Mahalingam A, Brauker J. Analysis of time lags and other sources of error of the dexcom seven continuous glucose monitor. Diabetes Technol Ther. 2009;11:689–95. CrossRefPubMed
Kirchsteiger H, Heinemann L, Freckmann G, et al. Performance comparison of cgm systems: mard values are not always a reliable indicator of cgm system accuracy. J Diabetes Sci Technol. 2015;9:1030–40. CrossRefPubMedPubMedCentral
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388:2254–63. CrossRefPubMed
Edge J, Acerini C, Campbell F, et al. An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Arch Dis Child. 2017;102:543–9. CrossRefPubMedPubMedCentral
Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8:55–73. CrossRefPubMed
Distiller LA, Cranston I, Mazze R. First clinical experience with retrospective flash glucose monitoring (FGM) analysis in south africa: characterizing glycemic control with ambulatory glucose profile. J Diabetes Sci Technol. 2016;10:1294–302. CrossRefPubMedPubMedCentral
Rodbard D. Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther. 2017;19:S25–37. CrossRefPubMed
Wright EE Jr, Gavin JR 3rd. Clinical use of professional continuous glucose monitoring. Diabetes Technol Ther. 2017;19:S12. CrossRefPubMed
Olafsdottir AF, Attvall S, Sandgren U, et al. A clinical trial of the accuracy and treatment experience of the flash glucose monitor freestyle libre in adults with type 1 diabetes. Diabetes Technol Ther. 2017;19:164–72. CrossRefPubMedPubMedCentral
Heinemann L. Finger pricking and pain: a never ending story. J Diabetes Sci Technol. 2008;2:919–21. CrossRefPubMedPubMedCentral
Polonsky WH, Hessler D, Ruedy KJ, Beck RW. The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the diamond randomized clinical trial. Diabetes Care. 2017;40:736–41. CrossRefPubMed
Pettus J, Edelman SV. Recommendations for using real-time continuous glucose monitoring (rtcgm) data for insulin adjustments in type 1 diabetes. J Diabetes Sci Technol. 2017;11:138–47. CrossRefPubMed
Aleppo G, Ruedy KJ, Riddlesworth TD, et al. Replace-bg: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. Diabetes Care. 2017;40:538–45. CrossRefPubMedPubMedCentral